Long time response with chemotherapy in ROS1 NSCLC patient with unusual metastatic site

During the last decade the therapeutic landscape of Non Small Cell Lung Cancer (NSCLC) has profoundly changed with the identification of actionable genetic alterations that defined molecularly selected subgroups of patients with specific clinic-pathological characteristics and increased sensitivity...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Biol Ther
Main Authors: Franchina, Tindara, Russo, Alessandro, Ricciardi, Giuseppina Rosaria, Liguori, Giuseppina, Herberg, Astrid, Normanno, Nicola, Adamo, Vincenzo
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2016
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5079394/
https://ncbi.nlm.nih.gov/pubmed/27611848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2016.1219822
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares